Approvals/TGA/Audenz Pandemic Influenza Vaccine H5N1 (surface antigen, inactivated, adjuvanted) suspension for injection PFS needle-free

Approved

STANDARD

Audenz Pandemic Influenza Vaccine H5N1 (surface antigen, inactivated, adjuvanted) suspension for injection PFS needle-free

Seqirus Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 048fa0da92f1833d
Product Name: Audenz Pandemic Influenza Vaccine H5N1 (surface antigen, inactivated, adjuvanted) suspension for injection PFS needle-free
Artg Id: 446671
Artg Name: AUDENZ Pandemic Influenza Vaccine H5N1 (surface antigen, inactivated, adjuvanted) suspension for injection PFS needle-free
Sponsor: Seqirus Pty Ltd
Company Detail Path: /organization/seqirus-pty-ltd
Artg Date: 2025-06-11
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Jun 17, 2025

Approval ID

048fa0da92f1833d

Type

Standard